○Yoshinori Tsukumo¹, Takayoshi Suzuki¹, Tokuyuki Yoshida¹, Nobumichi Ohoka¹, Eriko Uchida¹, Takao Inoue¹ (1. National Institute of Health Sciences, Division of Molecular Target and Gene Therapy products)

○Ryosuke Nakamura¹, Takeru Sugawara², Koji Fujinami², Katsuyo Doi², Yoshiro Saito¹ (1. Natl. Inst. Health Sci., 2. Torii Pharm. Co. Ltd.)

○Kaede Kato¹, Keisuke Tachibana², Daisuke Ando³, Ken-ichi Izutsu³, Masuo Kondoh² (1. Sch. Pharm. Sci., Osaka Univ., 2. Grad. Sch. Pharm. Sci., Osaka Univ., 3. Natl. Inst. Health Sci.)

○Akira Harazono¹, Hiroko Shibata¹, Akiko Watabe Ishii¹ (1. National Institute of Health Sciences)

○Masashi Hyuga¹, Riko Takahashi^1,2, Moe Nakamura^1,2, Minoru Tada¹, Akiko Ishii-Watabe¹ (1. Natl. Inst. Health Sci., 2. Meiji Pharm. Univ.)

○Hiroko Shibata¹, Akira HARAZONO¹, Masato KIYOSHI¹, Rie TAKESHITA², Teruhisa MANNEN², Tomohiro TAKASUGI³, Yu HAYASHI³, Michiko AKIMARU⁴, Shuntaro SAITO⁴, Tomoko MURAKAMI⁵, Mayumi NAKAKO⁵, Atsushi NAKANO⁶, Takuya SHINDO⁷, Kazuki IWASHITA⁸, Kazumasa YOKOYAMA⁹, Naomi OHBAYASHI¹⁰, Masatoshi YAMADA¹¹, Yukio HARA¹², Junji YAMASHITA¹², Kazuhiro MIYANABE¹³, Takeshi NISHIHAMA¹⁴, Akira MARUYAMA¹⁴, Yuya MIYAHARA¹⁵, Kenji SASAKI¹⁵, Shizuka KUROSAWA¹⁶, Elena KRAYUKHINA¹⁷, Masanori NODA¹⁷, Susumu UCHIYAMA¹⁸, Akiko ISHII-WATABE¹ (1. NIHS, 2. AJINOMOTO CO., INC., 3. Astellas Pharma Inc., 4. Daiichi Sankyo Co., Ltd., 5. Sumitomo Dainippon Pharma Co., Ltd., 6. Japan Blood Products Organization , 7. JCR Pharmaceuticals Co., Ltd., 8. Kyowa Kirin Co., Ltd., 9. Kissei Pharmaceutical Co.,Ltd, 10. Meiji Seika Pharma Co., Ltd., 11. Nippon Kayaku Co., Ltd., 12. NIHON PHARMACEUTICAL CO.,LTD., 13. Ono Pharmaceutical co., ltd., 14. Takeda Pharmaceutical Co., Ltd, 15. Mitsubishi Tanabe Pharma Co,, 16. Toray Research Center, Inc., 17. U-Medico Inc., 18. Grad. Sch. Eng, Osaka Univ.)

○Akari Kitamura¹, Nanako Hukuda¹, Chisato Takahashi¹, Mari Matsui², Satowa Suzuki², Keiko Maekawa¹ (1. Doshisha Women's College of Liberal Arts, 2. National Institute of Infectious Diseases)

○Junko Katayama¹, Machiko Ido¹, Satoshi Uenaga¹, Sachiyo Yoneda¹, Toshifumi Konda², Mari Matsui², Satowa Suzuki², Yukari Nakagawa¹ (1. PMRJ, 2. NIID)

○Takamasa Hirai¹, Ken Kono¹, Kiyoko Kataoka¹, Yoji Sato¹ (1. NIHS)

○Akira Okada^1,2, Shoji Sera^1,2, Maho Taguchi³, Hiroaki Yamada³, Naomi Nagai^1,2 (1. Fac. Pharm., Musashino Univ., 2. Res. Ins. Pharm. Sci., Musashino Univ., 3. Yokohama Univ. Pharm.)

○Keita Akagaki¹, Tomoaki Ishida¹, Kohei Jobu¹, Kei Kawada^1,2, Tetsushi Kawazoe^1,2, Shumpei Morisawa^1,2, Naohisa Tamura^1,2, Mitsuhiko Miyamura^1,2 (1. Department of Pharmacy, Kochi Medical School Hospital, 2. Graduate school of Integrated Arts and Sciences, Kochi University)

○Maho Taguchi¹, Akira Okada^2,3, Sera Shoji^2,3, Naomi Nagai^2,3, Hiroaki Yamada¹ (1. Yokohama Univ. Pharm. , 2. Fac. Pharm., Musashino Univ., 3. Res. Ins. Pharm. Sci., Musashino Univ.)

○Shinichi Kimura¹, Keiko Ogawa¹, Satoshi Ueshima¹, Osamu Noyori¹, Rumiko Hosoki¹ (1. Pharm.Sci,Ritsumeikan Univ.)